Baxter International Shares Dip 0.35% in Mixed Trading Session
April 20, 2023
Trending News ☀️
Baxter International ($NYSE:BAX) Inc. experienced a dip in stock prices on Tuesday, with shares dropping by 0.35% to $42.82. This drop occurred during a mixed trading session for the stock market, with some stocks seeing increases and others experiencing declines. It provides healthcare solutions, including drugs, vaccines, and therapies to patients around the world.
Additionally, the company has a presence in the home healthcare market, providing services such as home dialysis and infusion therapies. Baxter International Inc.’s strong presence in both the healthcare market and the home healthcare market makes it an attractive option for investors.
Share Price
Tuesday proved to be a mixed trading session for Baxter International Inc. (BAXTER INTERNATIONAL), as the stock opened at $43.0 and closed at $42.8, down 0.35% from its prior closing price of $43.0. Analysts will be monitoring the stock to see how it reacts in the days ahead. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Baxter International. More…
| Total Revenues | Net Income | Net Margin |
| 15.11k | -2.43k | -4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Baxter International. More…
| Operations | Investing | Financing |
| 1.21k | -931 | -1.44k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Baxter International. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 28.29k | 22.39k | 10.98 |
Key Ratios Snapshot
Some of the financial key ratios for Baxter International are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 10.0% | 2.0% | -12.8% |
| FCF Margin | ROE | ROA |
| 3.5% | -21.3% | -4.3% |
Analysis
At GoodWhale, we have conducted an in-depth analysis on BAXTER INTERNATIONAL‘s fundamentals, and we have come to the conclusion that it is a high risk investment. We have rated it as such due to its financial and business aspects. In order to provide our users with a comprehensive assessment of the company, we have identified three risk warnings in different parts of their balance sheet, cashflow statement and non-financial elements. To get an in-depth look at these risk warnings, we recommend our users to become registered members and access the analysis we have provided. More…
Peers
Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.
– Utah Medical Products Inc ($NASDAQ:UTMD)
The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.
– Clarity Medical Group Holding Ltd ($SEHK:01406)
According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.
– Merit Medical Systems Inc ($NASDAQ:MMSI)
Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.
Summary
Baxter International Inc. experienced a mixed trading session on Tuesday, with their shares closing the day 0.35% lower at $42.82. Overall, investing in Baxter International Inc. is a risky endeavor due to the volatility of the stock market. Analysts have suggested that investors conduct thorough research and analysis of the company’s financial health, competitive landscape, and risk management strategies before investing in Baxter International Inc. There are also other factors to consider such as economic trends, political events, and industry news. Investors should pay attention to these factors in order to make informed decisions when investing in Baxter International Inc.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
